CYP19A1 and breast carcinoma: Previously, we had reported that CYP19 (TTTA)n and CYP19 genetic polymorphisms haplotype AASA were closely associated with poor survival in premenopausal patients with LN-negative and HR-positive breast cancers [10, 36].